BioGeneration Ventures — 2022 Investments
6 investments dated 2022 · listed companies and verified rows first · show all
Carboledger provides compliance automation and AI-powered data validation for sustainability reporting across supply chains, helping companies meet evolving regulations like ISCC PLUS, REDCert, RED III, and CORSIA.
Climate TechEnterprise SoftwareSaaS
Nikha Garg(Founder)in
Co-investorsArka Venture LabsAvaana Capital
Lincode builds LIVIS, an AI-based visual inspection system for manufacturing quality control that lets factory teams train and deploy computer vision models for surface defect detection, assembly verification, and anomaly detection through a no-code interface.
Advanced ManufacturingAI & Machine LearningRobotics
Rajesh Iyengar(CEO)in
Co-investorsAlumni VenturesArka Venture LabsAugment VenturesBasecamp FundExpert DOJOGeek Ventures+5 more
River Biomedics develops human cardiac in vitro models used for drug target and compound validation, building a pipeline of cardiac therapies.
BiotechHealthtechMedical Devices
Robert Passier(Founder)in
Co-investorsKIKK CapitalBGVOost NL
TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.
BiotechMedical DevicesUtrecht, NL
Coen Maas(Co-founder)inSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKristof Vercruysse(Chief Executive Officer)inRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in
Co-investorsAndera PartnersCurie CapitalFund+Hadean VenturesInkefRotrip+1 more
Trainn is a learning management system (LMS) platform that combines video creation, guide authoring, and course delivery in a single interface designed for enterprises and startups.
AI & Machine LearningEdTechEnterprise SoftwareMarketing TechSaaSChennai, IN
VivekSumana
Co-investorsArka Venture LabsSpeciale Invest
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
FundaMental Pharma
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




















